Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of AK120 in Subjects With Moderate to Severe Atopic Dermatitis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the safety and efficacy of AK120 in adults with moderate to severe atopic dermatitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• AK120

Snippet

Sponsor: Akeso | Conditions: Atopic Dermatitis | Phase 2 | Status: COMPLETED